Urologic Oncology, 1873-2496

Journal

More filtering options
  1. 2019
  2. Cell-based evidence regarding the role of FSH in prostate cancer

    Dizeyi, N., Trzybulska, D., Yahia Al-Jebari, Ilpo Huhtaniemi & Yvonne Lundberg Giwercman, 2019, In : Urologic Oncology: Seminars and Original Investigations. 37, 4, p. 290.e1-290.e8

    Research output: Contribution to journalArticle

  3. Hospital readmissions after limited vs. extended lymph node dissection during open and robot-assisted radical prostatectomy

    Tyritzis, S. I., Wilderäng, U., Lantz, Α. W., Steineck, G., Hugosson, J., Anders Bjartell, Stranne, J., Haglind, E. & Wiklund, N. P., 2019, In : Urologic Oncology: Seminars and Original Investigations.

    Research output: Contribution to journalArticle

  4. 2018
  5. Recommendations for follow-up of muscle-invasive bladder cancer patients: A consensus by the international bladder cancer network

    Zuiverloon, T. C. M., van Kessel, K. E. M., Bivalacqua, T. J., Boormans, J. L., Ecke, T. H., Grivas, P. D., Kiltie, A. E., Fredrik Liedberg, Necchi, A., van Rhijn, B. W., Roghmann, F., Sanchez-Carbayo, M., Schmitz-Dräger, B. J., Wezel, F. & Kamat, A. M., 2018 Sep, In : Urologic Oncology: Seminars and Original Investigations. 36, 9, p. 423-431

    Research output: Contribution to journalArticle

  6. 2017
  7. 2015
  8. Cardiovascular risk with androgen deprivation therapy for prostate cancer: Potential mechanisms.

    Tivesten, Å., Pinthus, J. H., Clarke, N., Duivenvoorden, W. & Jan Nilsson, 2015, In : Urologic Oncology. 33, 11, p. 464-475

    Research output: Contribution to journalReview article

  9. 2014
  10. Assessment of the bone scan index in a randomized placebo-controlled trial of tasquinimod in men with metastatic castration-resistant prostate cancer (mCRPC).

    Armstrong, A. J., Kaboteh, R., Carducci, M. A., Damber, J-E., Stadler, W. M., Hansen, M., Edenbrandt, L., Forsberg, G., Nordle, O., Pili, R. & Morris, M. J., 2014, In : Urologic Oncology. 32, 8, p. 1308-1316

    Research output: Contribution to journalArticle

  11. Protein kinase A (PKA) pathway is functionally linked to androgen receptor (AR) in the progression of prostate cancer.

    Sarwar, M., Sandberg, S., Abrahamsson, P-A. & Persson, J. L., 2014, In : Urologic Oncology. 32, 1

    Research output: Contribution to journalArticle

  12. 2012
  13. 2011
  14. Serotonin activates MAP kinase and PI3K/Akt signaling pathways in prostate cancer cell lines.

    Dizeyi, N., Petter Hedlund, Anders Bjartell, Tinzl, M., Austild-Taskén, K. & Abrahamsson, P-A., 2011, In : Urologic Oncology. 29, p. 436-445

    Research output: Contribution to journalArticle

  15. 2010
  16. Understanding the agreement of histology of familial testicular tumors

    Liu, H., Jan Sundquist & Kari Hemminki, 2010, In : Urologic Oncology. 28, 5, p. 465-465

    Research output: Contribution to journalLetter

  17. 2009
  18. EAU-a work in progress-what comes next?

    Abrahamsson, P-A., 2009, In : Urologic Oncology. 27, 2, p. 125-126

    Research output: Contribution to journalLetter

  19. 2008
  20. Tissue microarray based analysis of prognostic markers in invasive bladder cancer: Much effort to no avail?

    Fredrik Liedberg, Anderson, H., Chebil, G., Mårten Fernö, Gudjonsson, S., Mattias Höglund, David Lindgren, Lundberg, L-M., Lövgren, K. & Wiking Månsson, 2008, In : Urologic Oncology. 26, 1, p. 17-24

    Research output: Contribution to journalArticle

  21. 2005
  22. Quality of life in patients with bladder cancer

    Gerharz, EW., Månsson, Å. & Wiking Månsson, 2005, In : Urologic Oncology. 23, 3, p. 201-207

    Research output: Contribution to journalArticle

  23. 2003
  24. 2002
  25. Localization and mRNA expression of somatostatin receptor subtypes in human prostatic tissue and prostate cancer cell lines.

    Dizeyi, N., Konrad, L., Anders Bjartell, Wu, H., Gadaleanu, V., Jens Ceder, Helboe, L. & Abrahamsson, P-A., 2002, In : Urologic Oncology. 7, 3, p. 91-98

    Research output: Contribution to journalArticle